Franchini M - Search Results

1

Passive immunotherapies for the next influenza pandemic.

Focosi D, Franchini M, Senefeld JW, Joyner MJ, Sullivan DJ, Pekosz A, Maggi F, Casadevall A. Focosi D, et al. Among authors: franchini m. Rev Med Virol. 2024 May;34(3):e2533. doi: 10.1002/rmv.2533. Rev Med Virol. 2024. PMID: 38635404 Review.

2

Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources.

Sullivan DJ, Franchini M, Joyner MJ, Casadevall A, Focosi D. Sullivan DJ, et al. Among authors: franchini m. medRxiv [Preprint]. 2022 Aug 22:2021.12.24.21268317. doi: 10.1101/2021.12.24.21268317. medRxiv. 2022. PMID: 35982681 Free PMC article. Updated. Preprint.

3

Lower anti-spike levels in B-cell-depleted patients after convalescent plasma transfusion suggest the need for repeated doses.

Focosi D, Senefeld JW, Joyner MJ, Sullivan D, Casadevall A, Bloch EM, Franchini M. Focosi D, et al. Among authors: franchini m. Br J Haematol. 2023 Jan;200(2):e22-e24. doi: 10.1111/bjh.18544. Epub 2022 Nov 7. Br J Haematol. 2023. PMID: 36342497 No abstract available.

4

Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1.

Sullivan DJ, Franchini M, Senefeld JW, Joyner MJ, Casadevall A, Focosi D. Sullivan DJ, et al. Among authors: franchini m. bioRxiv [Preprint]. 2022 Dec 16:2022.11.25.517977. doi: 10.1101/2022.11.25.517977. bioRxiv. 2022. PMID: 36482971 Free PMC article. Updated. Preprint.

5

Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines.

Focosi D, Franchini M, Senefeld JW, Casadevall A, Joyner MJ. Focosi D, et al. Among authors: franchini m. J Clin Virol Plus. 2023 Feb;3(1):100128. doi: 10.1016/j.jcvp.2022.100128. Epub 2022 Dec 6. J Clin Virol Plus. 2023. PMID: 36504695 Free PMC article. No abstract available.

6

Association between SARS-CoV-2 infection or vaccination and acquired hemophilia A: A case report and literature update.

Franchini M, Focosi D. Franchini M, et al. Thromb Res. 2023 Feb;222:7-11. doi: 10.1016/j.thromres.2022.12.010. Epub 2022 Dec 18. Thromb Res. 2023. PMID: 36542943 Free PMC article. No abstract available.

7

COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis.

Senefeld JW, Franchini M, Mengoli C, Cruciani M, Zani M, Gorman EK, Focosi D, Casadevall A, Joyner MJ. Senefeld JW, et al. Among authors: franchini m. JAMA Netw Open. 2023 Jan 3;6(1):e2250647. doi: 10.1001/jamanetworkopen.2022.50647. JAMA Netw Open. 2023. PMID: 36633846 Free PMC article.

8

How we manage cardiovascular disease in patients with hemophilia.

Franchini M, Focosi D, Mannucci PM. Franchini M, et al. Haematologica. 2023 Jul 1;108(7):1748-1757. doi: 10.3324/haematol.2022.282407. Haematologica. 2023. PMID: 36700406 Free PMC article. Review.

9

SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply.

Franchini M, Focosi D. Franchini M, et al. Thromb Res. 2023 Oct;230:152. doi: 10.1016/j.thromres.2023.01.024. Epub 2023 Feb 2. Thromb Res. 2023. PMID: 36740482 Free PMC article. No abstract available.

10

Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients With Coronavirus Disease 2019.

Bloch EM, Focosi D, Shoham S, Senefeld J, Tobian AAR, Baden LR, Tiberghien P, Sullivan DJ, Cohn C, Dioverti V, Henderson JP, So-Osman C, Juskewitch JE, Razonable RR, Franchini M, Goel R, Grossman BJ, Casadevall A, Joyner MJ, Avery RK, Pirofski LA, Gebo KA. Bloch EM, et al. Among authors: franchini m. Clin Infect Dis. 2023 Jun 8;76(11):2018-2024. doi: 10.1093/cid/ciad066. Clin Infect Dis. 2023. PMID: 36740590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,304 results

Search Page